AstraZeneca placed Wang on extended leave in December from his position as international executive vice president and China president, following his detention in October. Sign up here. Healthcare ...
AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...
AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results